DIABETIC RETINAL NEURODEGENERATION : A CASE STUDY

dc.contributor.authorYuldasheva NM
dc.contributor.authorBotirkhoja LB
dc.date.accessioned2025-12-31T15:38:24Z
dc.date.issued2024-01-04
dc.description.abstractAccording to the International Diabetes Federation, there are 537 million people with diabetes in the world [1]. Patients with diabetes mellitus (DM) are at a significantly higher risk of developing complications of the underlying disease, including diabetic retinopathy (DR). Diabetic retinopathy is not only the most common complication of diabetes but it is also recognized as the most severe, as it often leads to irreversible vision loss. In 2021, there were 103 million people worldwide with some form of diabetic retinopathy, accounting for 22.3% of the total number of diabetic patients
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/3610
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/49578
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/3610/3072
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 30 (2024): WBPH; 1-4
dc.source2749-3644
dc.subjectpeople
dc.subjectcomplication
dc.subjectcomplications
dc.titleDIABETIC RETINAL NEURODEGENERATION : A CASE STUDY
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
nm_2024_diabetic_retinal_neurodegeneration_a_cas.pdf
item.page.filesection.size
510.54 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections